These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 6184841)

  • 1. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
    Viero P; Cortelazzo S; Bassan R; Barbui T
    Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo platelet release in myeloproliferative disorders.
    Ireland H; Lane DA; Wolff S; Foadi M
    Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activation in myeloproliferative disorders.
    Cortelazzo S; Viero P; Barbui T
    Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and platelet beta-thromboglobulin in chronic myeloproliferative disorders.
    Endo Y; Mamiya S; Satoh M
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):118-23. PubMed ID: 6171982
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical significance of beta-thromboglobulin in patients with high platelet count.
    Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Bonvicini P; Girolami A
    Acta Haematol; 1984; 71(1):32-8. PubMed ID: 6197855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
    Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
    Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy.
    Aushri Z; Berginer V; Nathan I; Dvilansky A
    Int J Clin Pharmacol Res; 1983; 3(5):339-42. PubMed ID: 6206005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
    Viero P; Cortelazzo S; Barbui T
    Thromb Haemost; 1984 Jul; 51(3):411. PubMed ID: 6208631
    [No Abstract]   [Full Text] [Related]  

  • 9. The value of beta TG/PF4 ratio in patients with high platelet count.
    Fabris F; Luzzatto G; Girolami A
    Thromb Haemost; 1985 Apr; 53(2):288-9. PubMed ID: 2410998
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
    Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
    J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
    Al-Mondhiry H; Pierce WS; Pennock JL
    J Lab Clin Med; 1985 Mar; 105(3):397-402. PubMed ID: 2579177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function studies in myeloproliferative disorders.
    Pfliegler G; Boda Z; Udvardy M; Kiss A; Telek B; Pecze K; Nagy P; Rak K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):655-62. PubMed ID: 2435631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet hyperfunction in patients with chronic airways obstruction.
    Cordova C; Musca A; Violi F; Alessandri C; Perrone A; Balsano F
    Eur J Respir Dis; 1985 Jan; 66(1):9-12. PubMed ID: 2579841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets in myeloproliferative disorders. II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density.
    Caranobe C; Sie P; Nouvel C; Laurent G; Pris J; Boneu B
    Scand J Haematol; 1980 Oct; 25(4):289-95. PubMed ID: 7209398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
    Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
    Zuk E
    Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of beta-thromboglobulin levels in diabetic patients controlled with the artificial pancreas].
    Voisin P; Rousselle D; Drouin P; Stoltz JF
    Biomed Pharmacother; 1982 Jan; 36(1):19-23. PubMed ID: 6181821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders.
    Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1139-44. PubMed ID: 6800179
    [No Abstract]   [Full Text] [Related]  

  • 19. Abnormal platelet serotonin uptake and binding sites in myeloproliferative disorders.
    Caranobe C; Sié P; Fernandez F; Pris J; Moatti S; Boneu B
    Thromb Haemost; 1984 Jul; 51(3):349-53. PubMed ID: 6593892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vivo platelet activation in mild arterial hypertension].
    Guicheney P; Baudouin-Legros M; Meyer P
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):808-11. PubMed ID: 2959230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.